ROSEN, TOP-RANKED LAW FIRM, Urges AstraZeneca PLC Investors to Secure Counsel Ahead of Important Deadline in Company’s First-Filing Securities Class Action

New York, New York–(Newsfile Corp. – December 30, 2024) – WHY: The Rosen Law Firm, a global investor rights law firm, announces that it has filed a class action lawsuit on behalf of purchasers of AstraZeneca PLC (NASDAQ: LON: ) securities between February 23, 2022 and December 17, 2024, both dates, inclusive (“Class Period “). A class action lawsuit has already been filed. If you want to be the chief prosecutor, you have to move the court no later than February 21, 2025 in a securities class action lawsuit filed first by the company.

SO WHAT: If you purchased AstraZeneca (NASDAQ: ) securities during the Class Period, you may be entitled to compensation without paying any out-of-pocket fees or expenses through a contingency fee arrangement.

WHAT TO DO NEXT: To join the AstraZeneca class action, go to https://rosenlegal.com/submit-form/?case_id=1331 or call Phillip Kim, Esq. toll free at 866-767-3653 or email case@rosenlegal.com for information about the class action. A class action lawsuit has already been filed. If you want to be the chief prosecutor, you have to move the court no later than February 21, 2025. The lead plaintiff is the representative party that acts on behalf of the other class members in the conduct of the litigation.

WHY ROSEN’S LAW: We encourage investors to choose a qualified advisor with experience in successful leadership roles. Often the firms issuing the notices do not have comparable experience, resources or any significant recognition from their peers. Be wise in choosing an advisor. The Rosen Law Firm represents investors worldwide, concentrating its practice in securities class actions and equity derivative litigation. The Rosen Law Firm secured the largest securities class action settlement to date against a Chinese company at the time. The Rosen Law Firm is ranked #1 by ISS Securities Class Action (WA:) Services for numerous securities class action settlements in 2017. The firm has been ranked in the top 4 every year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone, the company secured more than $438 million for investors. In 2020, founding partner Laurence Rosen was named a Law360 Claimant Bar Association Titan. Many of the firm’s lawyers have been recognized by Lawdragon and Super Lawyers.

CASE DETAILS: According to the complaint, during the Lecture Period, the defendants made materially false and/or misleading statements and/or failed to disclose that: (1) AstraZeneca was involved in insurance fraud in China; (2) as a result, AstraZeneca faced increased legal exposure in China, which ultimately resulted in the detention of the President of AstraZeneca China by Chinese law enforcement authorities; (3) as a result, AstraZeneca underestimated its legal risks; (4) the foregoing, if disclosed, could materially harm AstraZeneca’s business activities in China; and (5) as a result, the defendant’s statements about its business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details came to market, the lawsuit alleges, investors suffered damages.

To join the AstraZeneca class action, go to https://rosenlegal.com/submit-form/?case_id=1331 call Phillip Kim, Esq. toll free at 866-767-3653 or email case@rosenlegal.com for information about the class action.

No class is certified. Until the class is certified, you will not be represented by an attorney unless you retain one. You can choose a lawyer of your choice. You can also remain an absent member of the class and do nothing at this time. An investor’s ability to participate in a potential future recovery does not depend on whether it is the lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook (NASDAQ:): https:/ /www.facebook.com/rosenlawfirm.

Advertising of lawyers. Previous results do not guarantee a similar outcome.

——————————–

To view the original version of this press release, visit https://www.newsfilecorp.com/release/235568